{"DataElement":{"publicId":"7206968","version":"1","preferredName":"Gemtuzumab Ozogamicin Total Dose Administered Known Unknown Indicator","preferredDefinition":"The indicator that describes if the total dose of gemtuzumab ozogamicin administered was known or unknown.","longName":"7206966v1.0:2935542v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7206966","version":"1","preferredName":"Gemtuzumab Ozogamicin Total Dose Administered","preferredDefinition":"A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)_Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The act of having given something (e.g., a medication or test).","longName":"3031382v1.0:6428088v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3031382","version":"1","preferredName":"Gemtuzumab Ozogamicin","preferredDefinition":"A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)","longName":"C1806","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gemtuzumab Ozogamicin","conceptCode":"C1806","definition":"A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin.  In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"82FAC8EC-DAB5-00C8-E040-BB89AD432EA4","latestVersionIndicator":"Yes","beginDate":"2010-03-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-29","modifiedBy":"ONEDATA","dateModified":"2010-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6428088","version":"1","preferredName":"Total Dose Administered","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:The act of having given something (e.g., a medication or test).","longName":"C25304:C25488:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"754D5FF2-26B1-12D8-E053-F662850A9450","latestVersionIndicator":"Yes","beginDate":"2018-09-07","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-07","modifiedBy":"ONEDATA","dateModified":"2018-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A10E1A5B-203E-214E-E053-F662850A1342","latestVersionIndicator":"Yes","beginDate":"2020-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-03-17","modifiedBy":"KUMMEROA","dateModified":"2020-10-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2935542","version":"1","preferredName":"Known Unknown Indicator","preferredDefinition":"Recognized, familiar, or within the scope of knowledge._Not known, not observed, not recorded, or refused._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"2935542v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Known","valueDescription":"Known","ValueMeaning":{"publicId":"2934435","version":"1","preferredName":"Known","longName":"2934435","preferredDefinition":"Recognized, familiar, or within the scope of knowledge.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7181A67F-9F52-BB55-E040-BB89AD432FA8","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"SCOTTLO","dateCreated":"2009-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BF55B58-25B1-A4FE-E040-BB89AD436660","beginDate":"2009-08-25","endDate":null,"createdBy":"WHITES","dateCreated":"2009-12-30","modifiedBy":"ONEDATA","dateModified":"2009-12-30","deletedIndicator":"No"},{"value":"Not known","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BF55B58-25C5-A4FE-E040-BB89AD436660","beginDate":"2009-08-25","endDate":"2013-09-04","createdBy":"WHITES","dateCreated":"2009-12-30","modifiedBy":"KUMMEROA","dateModified":"2013-09-04","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E58FF59D-26B2-0DD0-E040-BB89AD4320D4","beginDate":"2013-09-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-09-04","modifiedBy":"ONEDATA","dateModified":"2013-09-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2935541","version":"1","preferredName":"Known Unknown Indicator","preferredDefinition":"Recognized, familiar, or within the scope of knowledge.:Not known, not observed, not recorded, or refused.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C80137:C17998:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F8C85B-6EE5-9265-E040-BB89AD433FDD","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-25","modifiedBy":"ONEDATA","dateModified":"2009-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F8C85B-6EF6-9265-E040-BB89AD433FDD","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-25","modifiedBy":"KUMMEROA","dateModified":"2013-12-13","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Was the total dose of gemtuzu","type":"Preferred Question Text","description":"Was the total dose of gemtuzumab ozogamicin administered known or unknown?","url":null,"context":"NHLBI"},{"name":"Total gemtuzumab ozogamicin (Mylotarg) dose given as part of this line of therapy","type":"Application Standard Question Text","description":"Total gemtuzumab ozogamicin (Mylotarg) dose given as part of this line of therapy","url":null,"context":"NHLBI"},{"name":"Total gemtuzumab ozogamicin (Mylotarg) dose given as part of this line of therapy","type":"Alternate Question Text","description":"Total gemtuzumab ozogamicin (Mylotarg) dose given as part of this line of therapy","url":null,"context":"NHLBI"},{"name":"Total gemtuzumab ozogamicin (Mylotarg/trademark/) dose given as part of this line of therapy","type":"Alternate Question Text","description":"Total gemtuzumab ozogamicin (Mylotarg/trademark/) dose given as part of this line of therapy","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A112725D-5F8B-0F00-E053-F662850A2AEE","latestVersionIndicator":"Yes","beginDate":"2020-03-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-03-17","modifiedBy":"KUMMEROA","dateModified":"2020-10-07","changeDescription":". System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}